(Q53526869)
Statements
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways (English)
Sophie Park
Pierre Sujobert
François Dreyfus
Patrick Mayeux
Catherine Lacombe
18 September 2007